Lysophosphatidic acid stimulates inflammatory cascade in airway epithelial cells

被引:20
作者
Barekzi, Elizabeth
Roman, Jessica
Hise, Kathleen
Georas, Steve
Steinke, John W. [1 ]
机构
[1] Univ Virginia, Hlth Syst, Dept Med,Asthma & Allerg Dis Ctr, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22903 USA
[2] Johns Hopkins Univ, Johns Hopkins Asthma & Allergy Ctr, Dept Med, Baltimore, MD 21218 USA
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 2006年 / 74卷 / 06期
关键词
D O I
10.1016/j.plefa.2006.03.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nasal polyps are benign outgrowths originating from the anterior ethmoid and maxillary sinuses. The events leading to polyp formation are unknown but evidence points to damage of the mucousal epithelium. Lysophosphatidic acid (LPA) is a water-soluble phospholipid that has been implicated in the development of allergic inflammation. We hypothesized LPA may be an important mediator in the initiation and maintenance of the inflammatory milieu of the polyp. Data was compared from unstimulated lung epithelial and when possible nasal polyp-derived epithelial cells with LPA stimulated cells. LPA receptors I and 2 were constitutively expressed on lung and nasal polyp-derived epithelial cells and receptor mRNA expression was decreased upon stimulation with IL-13 and IFN-gamma. When cells were treated with LPA, cellular proliferation was stimulated 2.2 fold. Supernatants from LPA stimulated cells displayed decreases in the levels of VEGF, GM-CSF, and TNF-alpha at 24 h which returned to normal or increased at 48 h. Our results suggest epithelial cells undergo rapid proliferation in response to LPA resulting in a transient decrease in inflammatory cytokines followed by an upregulation of these cytokines that could lead to increased inflammation. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:357 / 363
页数:7
相关论文
共 28 条
[1]   Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction [J].
Arbibe, L ;
Koumanov, K ;
Vial, D ;
Rougeot, C ;
Faure, G ;
Havet, N ;
Longacre, S ;
Vargaftig, BB ;
Béréziat, G ;
Voelker, DR ;
Wolf, C ;
Touqui, L .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (06) :1152-1160
[2]   IL-5 synthesis is upregulated in human nasal polyp tissue [J].
Bachert, C ;
Wagenmann, M ;
Hauser, U ;
Rudack, C .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (06) :837-842
[3]   INDUCTION OF BOVINE BRONCHIAL EPITHELIAL-CELL FILOPODIA BY TETRADECANOYL PHORBOL ACETATE, CALCIUM IONOPHORE, AND LYSOPHOSPHATIDIC ACID [J].
BECKMANN, JD ;
ROMBERGER, DJ ;
RENNARD, SI ;
SPURZEM, JR .
JOURNAL OF CELLULAR PHYSIOLOGY, 1995, 164 (01) :123-131
[4]   Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer [J].
Boucharaba, A ;
Serre, CM ;
Grès, S ;
Saulnier-Blache, JS ;
Bordet, JC ;
Guglielmi, J ;
Clézardin, P ;
Peyruchaud, O .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (12) :1714-1725
[5]   Lysophosphatidic acid and EGF stimulate mitogenesis in human airway smooth muscle cells [J].
Cerutis, DR ;
Nogami, M ;
Anderson, JL ;
Churchill, JD ;
Romberger, DJ ;
Rennard, SI ;
Toews, ML .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1997, 273 (01) :L10-L15
[6]  
Ediger TL, 2000, J PHARMACOL EXP THER, V294, P1076
[7]   Eosinophilic mucin rhinosinusitis: A distinct clinicopathological entity [J].
Ferguson, BJ .
LARYNGOSCOPE, 2000, 110 (05) :799-813
[8]   The LPA receptors [J].
Fukushima, N ;
Chun, J .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2001, 64 (1-4) :21-32
[9]   Lysophosphatidic acid as a phospholipid mediator: Pathways of synthesis [J].
Gaits, F ;
Fourcade, O ;
LeBalle, F ;
Gueguen, G ;
Gaige, B ;
GassamaDiagne, A ;
Fauvel, J ;
Salles, JP ;
Mauco, G ;
Simon, MF ;
Chap, H .
FEBS LETTERS, 1997, 410 (01) :54-58
[10]  
GOETZL E, 2001, J CLIN INVEST, V114, P1531